Insider Trading activities of Dialysis Corp Of America insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dialysis Corp Of America since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dialysis Corp Of America since year 2005. Table 2 shows the detailed insider transactions of Dialysis Corp Of America since 2005. The reporting company's ticker symbol is DCAI. The reporting company's CIK number is 201653.
The total value of stock buying since 2005 is $51,645.
The total value of stock sales since 2005 is $4,584,334.
The total value of stock option exercises since 2005 is $766,489.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Dialysis Corp Of America (DCAI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2009-06 0 $0 2,000 $10,400 7,834 $31,491
2009-05 6,700 $29,961 0 $0 0 $0
2008-06 3,000 $21,684 0 $0 0 $0
2007-10 0 $0 10,000 $93,835 0 $0
2007-01 0 $0 2,000 $27,738 0 $0
2006-08 0 $0 10,000 $131,000 0 $0
2006-03 0 $0 38,376 $503,368 262,500 $734,998
2005-11 0 $0 251,624 $3,362,202 0 $0
2005-04 0 $0 23,428 $455,791 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Dialysis Corp Of America insiders (DCAI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2009-06-08 Bienenstock Alexander (Director) Option Ex 1,417 4.02 5,696
2009-06-08 Trause Robert W (Director) Option Ex 1,417 4.02 5,696
2009-06-08 Fischbein Peter D (Director) Option Ex 5,000 4.02 20,099
2009-06-01 Bienenstock Alexander (Director) Sale 2,000 5.20 10,400
2009-05-29 Zimmerman Joanne (VP, Clinical Services) Buy 1,000 4.60 4,600
2009-05-15 Carey Thomas Patrick (VP, Operations) Buy 3,500 4.42 15,470
2009-05-15 Everett Stephen W (President & CEO) Buy 1,500 4.55 6,825
2009-05-14 Zimmerman Joanne (VP, Clinical Services) Buy 700 4.38 3,066
2008-06-24 Carey Thomas Patrick (Vice President, Operations) Buy 1,500 7.22 10,830
2008-06-10 Jeanneret Andrew J (VP Finance, CFO) Buy 700 7.30 5,110
2008-06-09 Jeanneret Andrew J (VP Finance, CFO) Buy 800 7.18 5,744
2007-10-08 Bienenstock Alexander (Director) Sale 6,295 9.23 58,102
2007-10-02 Bienenstock Alexander (Director) Sale 1,705 9.58 16,333
2007-10-01 Bienenstock Alexander (Director) Sale 2,000 9.70 19,400
2007-01-12 Langbein Thomas K (Director) Sale 1,900 13.87 26,353
2007-01-09 Langbein Thomas K (Director) Sale 100 13.85 1,385
2006-08-16 Bienenstock Alexander (Director) Sale 10,000 13.10 131,000
2006-03-29 Rowe Michael (Vice President, Operations) Option Ex 175,000 2.19 383,250
2006-03-22 Everett Stephen W (President and CEO) Sale 18,376 13.51 248,259
2006-03-13 Fischbein Peter D (Director) Sale 8,806 12.75 112,276
2006-03-09 Fischbein Peter D (Director) Sale 200 12.75 2,550
2006-03-08 Fischbein Peter D (Director) Sale 10,994 12.76 140,283
2006-03-07 Everett Stephen W (President and CEO) Option Ex 37,500 4.02 150,749
2006-03-07 Langbein Thomas K (Director) Option Ex 50,000 4.02 200,999
2005-11-23 Everett Stephen W (President and CEO) Sale 81,624 13.69 1,117,432
2005-11-23 Langbein Thomas K (Director) Sale 70,000 13.82 967,050
2005-11-18 Langbein Thomas K (Director) Sale 40,000 12.68 507,200
2005-11-15 Langbein Thomas K (Director) Sale 60,000 12.84 770,520
2005-04-01 Trause Robert W (Director) Sale 23,428 19.46 455,791

Insider trading activities including stock purchases, stock sales, and option exercises of DCAI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dialysis Corp Of America (symbol DCAI, CIK number 201653) see the Securities and Exchange Commission (SEC) website.